Lori M Minasian

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Prevention and early detection clinical trials: opportunities for primary care providers and their patients
    Leslie G Ford
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    CA Cancer J Clin 53:82-101. 2003
  2. ncbi request reprint Health-related quality of life and symptom management research sponsored by the National Cancer Institute
    Lori M Minasian
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7340, USA
    J Clin Oncol 25:5128-32. 2007
  3. ncbi request reprint Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience
    David R Buchanan
    National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:6682-9. 2005
  4. pmc Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation
    Andrew N Freedman
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7393, USA
    J Natl Cancer Inst 102:1698-705. 2010
  5. doi request reprint A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Barbara K Dunn
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
    Nutr Cancer 62:896-918. 2010
  6. pmc Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program
    Lori M Minasian
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Cancer 116:4440-9. 2010
  7. ncbi request reprint Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:591-8. 2005
  8. ncbi request reprint Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience
    Worta McCaskill-Stevens
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    J Clin Oncol 23:5247-54. 2005
  9. ncbi request reprint Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
  10. ncbi request reprint Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Scott M Lippman
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Natl Cancer Inst 97:94-102. 2005

Detail Information

Publications11

  1. ncbi request reprint Prevention and early detection clinical trials: opportunities for primary care providers and their patients
    Leslie G Ford
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    CA Cancer J Clin 53:82-101. 2003
    ....
  2. ncbi request reprint Health-related quality of life and symptom management research sponsored by the National Cancer Institute
    Lori M Minasian
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7340, USA
    J Clin Oncol 25:5128-32. 2007
    ..The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations...
  3. ncbi request reprint Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience
    David R Buchanan
    National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:6682-9. 2005
    ..To identify major research-design issues in proposals submitted by investigators in the Community Clinical Oncology Program (CCOP) for clinical trials of complementary and alternative medicine (CAM) for cancer-symptom management...
  4. pmc Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation
    Andrew N Freedman
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7393, USA
    J Natl Cancer Inst 102:1698-705. 2010
    ....
  5. doi request reprint A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Barbara K Dunn
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
    Nutr Cancer 62:896-918. 2010
    ..07, P = 0.16) were observed. SELECT data show that neither selenium nor vitamin E, alone or together, in the doses and formulations used, prevented prostate cancer in this heterogeneous population of healthy men...
  6. pmc Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program
    Lori M Minasian
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Cancer 116:4440-9. 2010
    ..By describing its keys to success, this article provides practical guidance to cancer-focused, provider-based research networks as well as those in other disciplines...
  7. ncbi request reprint Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:591-8. 2005
    ..To examine how quality of life (QOL) is prospectively conceptualized, defined, and measured in the symptom management clinical trials supported by the National Cancer Institute Community Clinical Oncology Program (CCOP)...
  8. ncbi request reprint Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience
    Worta McCaskill-Stevens
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    J Clin Oncol 23:5247-54. 2005
    ..This article examines temporal trends in MBCCOP accruals to cancer prevention and control (CP/C) and cancer treatment trials and the racial distribution of study participants, along with the major factors affecting minority enrollment...
  9. ncbi request reprint Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
    ....
  10. ncbi request reprint Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Scott M Lippman
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Natl Cancer Inst 97:94-102. 2005
    ....
  11. ncbi request reprint Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Elise D Cook
    Department of Clinical Cancer Prevention, Unit 1360, The University of Texas M D Anderson Cancer Center, Houston 77230 1439, USA
    Clin Trials 2:436-42. 2005
    ..The goal for black participants was set at 20% because of their proportion in the United States population and their prevalence of prostate cancer...